Ataluren for the treatment of cystic fibrosis. - Wikidata - awgldk - TriplyDB

Ataluren for the treatment of cystic fibrosis.

Ataluren for the treatment of cystic fibrosis.

http://www.wikidata.org/entity/Q53637088

about

Ataluren for the treatment of cystic fibrosis.

http://www.wikidata.org/entity/Q53637088

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Ataluren for the treatment of cystic fibrosis.

@en

Ataluren for the treatment of cystic fibrosis.

@nl

type

label

Ataluren for the treatment of cystic fibrosis.

@en

Ataluren for the treatment of cystic fibrosis.

@nl

prefLabel

Ataluren for the treatment of cystic fibrosis.

@en

Ataluren for the treatment of cystic fibrosis.

@nl

P1433

Q53637088-70DAC537-7D00-4E4C-AB43-538071624D52

P1476

Q53637088-1D9E74A4-061D-43BB-90EB-2354C0DBBD52

P2093

Q53637088-115056D0-1461-41E8-9B45-2769B7B89CE6

Q53637088-A683CB3A-96A0-44F4-8310-687F9EAFF703

P2860

Q53637088-034D475B-C09C-4D18-AF79-4931B2EB2F6B

Q53637088-082DEEA7-1D99-42BE-8A81-899BF266EC13

Q53637088-08E92E6A-5D48-4677-AC48-6369ADACBC5D

Q53637088-104548DA-A85C-46BD-958E-AA5F0FF34244

Q53637088-1B503EF7-B74D-4B29-8880-3F24D651EE84

Q53637088-1BF28A42-70D2-40B3-A956-29EE65AE900F

Q53637088-2C0DD1A4-BF94-4A6A-A9A7-1078197422DF

Q53637088-2D2E429B-A003-4BD2-BD55-B6D5B7FF7E5E

Q53637088-3544486F-127D-4AF7-8D5D-844B6BEE2946

Q53637088-41BE9D19-230D-43C9-A39F-5B6386ED870E

P31

Q53637088-6B75A727-C897-4BFC-89CD-CFF6E066C268

P356

Q53637088-E14684FD-F791-4F4F-9D98-3D66CC6B1227

P50

Q53637088-DB8E6B37-CADE-47FC-9480-616242849E95

P577

Q53637088-812732F5-B119-4FE3-95F1-C6CA9F1816AB

P698

Q53637088-62E7FF51-392A-4F8B-BAFB-AEB01D2336DC

P921

Q53637088-4D219DD2-B4DC-400E-AC3C-DAA7844B34C4

P356

17476348.2016.1150181

P1433

Expert Review of Respiratory Medicine

P1476

Ataluren for the treatment of cystic fibrosis.

@en

P2093

David Shoseyov

http://www.w3.org/2001/XMLSchema#string

Michael Wilschanski

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the cystic fibrosis gene: chromosome walking and jumping

Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening

Cystic fibrosis

A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays

Identification of the cystic fibrosis gene: genetic analysis

Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor

Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR).

Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers.

PTC124 targets genetic disorders caused by nonsense mutations.

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.

P31

scholarly article

P356

10.1586/17476348.2016.1150181

http://www.w3.org/2001/XMLSchema#string

P50

Malena Cohen-Cymberknoh

P577

2016-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26840186

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis